Related Experiment Video
Updated: Feb 23, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
The Notch-3 receptor: A molecular switch to tumorigenesis?
Shakeel Inder1, Sinead O'Rourke2, Niamh McDermott2
1Translational Radiobiology and Molecular Oncology, Applied Radiation Therapy Trinity, Trinity College Dublin, Dublin, Ireland; Department of Urology, St James's Hospital, Dublin, Ireland.
Abstract:
The Notch pathway is a highly conserved pathway increasingly implicated with the progression of human cancers. Of the four existing receptors associated with the pathway, the deregulation in the expression of the Notch-3 receptor is associated with more aggressive disease and poor prognosis. Selective targeting of this receptor has the potential to enhance current anti-cancer treatments. Molecular profiling strategies are increasingly incorporated into clinical decision making. This review aims to evaluate the clinical potential of Notch-3 within this new era of personalised medicine.
Insights
The Notch pathway, particularly Notch-3 receptor, is linked to aggressive cancers. Targeting Notch-3 shows promise for improving cancer therapies in personalized medicine.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- The Notch signaling pathway is crucial in cellular processes and is increasingly recognized for its role in human cancer progression.
- Aberrant Notch pathway signaling, specifically involving the Notch-3 receptor, correlates with more aggressive cancer phenotypes and poorer patient outcomes.
- Current anti-cancer strategies may be enhanced by targeting specific components of the Notch pathway.
Purpose of the Study:
- To review the clinical significance of the Notch-3 receptor in the context of personalized medicine.
- To evaluate the therapeutic potential of targeting Notch-3 for various human cancers.
- To assess how molecular profiling can inform Notch-3-targeted cancer treatment decisions.
Main Methods:
- Literature review of studies investigating the Notch pathway and Notch-3 receptor in cancer.
- Analysis of data linking Notch-3 expression levels to cancer aggressiveness and prognosis.
- Evaluation of preclinical and clinical evidence for Notch-3-targeted therapies.
- Assessment of the role of molecular profiling in identifying patients who may benefit from Notch-3 targeting.
Main Results:
- Deregulation of Notch-3 receptor expression is a marker of aggressive disease and poor prognosis across multiple cancer types.
- Selective inhibition or modulation of Notch-3 offers a promising strategy to augment existing cancer treatments.
- Molecular profiling techniques are essential for identifying the clinical utility of Notch-3 as a therapeutic target.
Conclusions:
- The Notch-3 receptor represents a significant therapeutic target in oncology.
- Targeting Notch-3 holds potential for improving treatment efficacy in cancers characterized by its aberrant expression.
- Integrating Notch-3 targeting with molecular profiling aligns with the principles of personalized cancer medicine.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Hedgehog Signaling Pathway
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Non-Canonical Wnt Signaling Pathways

